List of Tables
    Table 1. Dementia Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Dementia Drugs Market Trends
    Table 3. Dementia Drugs Market Drivers
    Table 4. Dementia Drugs Market Challenges
    Table 5. Dementia Drugs Market Restraints
    Table 6. Global Dementia Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Dementia Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Dementia Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Dementia Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Dementia Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Dementia Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Dementia Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Dementia Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Dementia Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Dementia Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Dementia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Dementia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia Drugs as of 2021)
    Table 18. Top Players of Dementia Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Dementia Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Dementia Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Dementia Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Dementia Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Dementia Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Dementia Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Dementia Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Dementia Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Dementia Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Dementia Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Dementia Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Dementia Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Dementia Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Dementia Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Dementia Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Dementia Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Dementia Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Dementia Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Dementia Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Dementia Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Dementia Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Dementia Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Eisai, Inc Corporation Information
    Table 43. Eisai, Inc Description and Business Overview
    Table 44. Eisai, Inc Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Eisai, Inc Dementia Drugs Product
    Table 46. Eisai, Inc Recent Development
    Table 47. Janssen Pharmaceuticals, Inc Corporation Information
    Table 48. Janssen Pharmaceuticals, Inc Description and Business Overview
    Table 49. Janssen Pharmaceuticals, Inc Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Janssen Pharmaceuticals, Inc Product
    Table 51. Janssen Pharmaceuticals, Inc Recent Development
    Table 52. Biogen Pharmaceuticals Corporation Information
    Table 53. Biogen Pharmaceuticals Description and Business Overview
    Table 54. Biogen Pharmaceuticals Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Biogen Pharmaceuticals Product
    Table 56. Biogen Pharmaceuticals Recent Development
    Table 57. Forest Laboratories, Inc Corporation Information
    Table 58. Forest Laboratories, Inc Description and Business Overview
    Table 59. Forest Laboratories, Inc Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Forest Laboratories, Inc Product
    Table 61. Forest Laboratories, Inc Recent Development
    Table 62. Eli Lilly and Company Corporation Information
    Table 63. Eli Lilly and Company Description and Business Overview
    Table 64. Eli Lilly and Company Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Eli Lilly and Company Product
    Table 66. Eli Lilly and Company Recent Development
    Table 67. Novartis AG Corporation Information
    Table 68. Novartis AG Description and Business Overview
    Table 69. Novartis AG Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Novartis AG Product
    Table 71. Novartis AG Recent Development
    Table 72. Sanofi S.A Corporation Information
    Table 73. Sanofi S.A Description and Business Overview
    Table 74. Sanofi S.A Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Sanofi S.A Product
    Table 76. Sanofi S.A Recent Development
    Table 77. AstraZeneca GmbH Corporation Information
    Table 78. AstraZeneca GmbH Description and Business Overview
    Table 79. AstraZeneca GmbH Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. AstraZeneca GmbH Product
    Table 81. AstraZeneca GmbH Recent Development
    Table 82. F. Hoffmann-La Roche Corporation Information
    Table 83. F. Hoffmann-La Roche Description and Business Overview
    Table 84. F. Hoffmann-La Roche Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. F. Hoffmann-La Roche Product
    Table 86. F. Hoffmann-La Roche Recent Development
    Table 87. Merck & Co., Inc Corporation Information
    Table 88. Merck & Co., Inc Description and Business Overview
    Table 89. Merck & Co., Inc Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Merck & Co., Inc Product
    Table 91. Merck & Co., Inc Recent Development
    Table 92. Valeant Pharmaceutical International Corporation Information
    Table 93. Valeant Pharmaceutical International Description and Business Overview
    Table 94. Valeant Pharmaceutical International Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Valeant Pharmaceutical International Product
    Table 96. Valeant Pharmaceutical International Recent Development
    Table 97. Pfizer Inc Corporation Information
    Table 98. Pfizer Inc Description and Business Overview
    Table 99. Pfizer Inc Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 100. Pfizer Inc Product
    Table 101. Pfizer Inc Recent Development
    Table 102. Teva Pharmaceuticals Industries Corporation Information
    Table 103. Teva Pharmaceuticals Industries Description and Business Overview
    Table 104. Teva Pharmaceuticals Industries Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 105. Teva Pharmaceuticals Industries Product
    Table 106. Teva Pharmaceuticals Industries Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Dementia Drugs Customers List
    Table 110. Dementia Drugs Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dementia Drugs Product Picture
    Figure 2. Global Dementia Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Dementia Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Dementia Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Dementia Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Dementia Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Dementia Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Dementia Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Dementia Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Dementia Drugs Report Years Considered
    Figure 11. Product Picture of MAO Inhibitors
    Figure 12. Product Picture of Cholinesterase Inhibitors
    Figure 13. Product Picture of Glutamate Inhibitors
    Figure 14. Global Dementia Drugs Market Share by Type in 2022 & 2028
    Figure 15. Global Dementia Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Dementia Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Dementia Drugs Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Dementia Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Dementia Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 20. United States Dementia Drugs Market Share by Type in 2022 & 2028
    Figure 21. United States Dementia Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Dementia Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Dementia Drugs Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Dementia Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Dementia Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 26. Product Picture of Hospital Pharmacies
    Figure 27. Product Picture of Retail Pharmacies
    Figure 28. Product Picture of Others
    Figure 29. Global Dementia Drugs Market Share by Application in 2022 & 2028
    Figure 30. Global Dementia Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Dementia Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Dementia Drugs Sales by Application (2017-2028) & (K Units)
    Figure 33. Global Dementia Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Dementia Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 35. United States Dementia Drugs Market Share by Application in 2022 & 2028
    Figure 36. United States Dementia Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Dementia Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Dementia Drugs Sales by Application (2017-2028) & (K Units)
    Figure 39. United States Dementia Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Dementia Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 41. North America Dementia Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 42. North America Dementia Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Dementia Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. Europe Dementia Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Dementia Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 53. Asia-Pacific Dementia Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Dementia Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 65. Latin America Dementia Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Dementia Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 70. Middle East & Africa Dementia Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Dementia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Dementia Drugs Value Chain
    Figure 75. Dementia Drugs Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed